PCOS and Exercise Statistics You Need to Know in 2026

Every stat below traces to a peer-reviewed study, systematic review, or a named clinical guideline — no listicle-of-listicles numbers. Where a stat comes from a meta-analysis, the trial count and sample size are given so you can judge the strength of the evidence yourself.

By Coach Aditya Narayan, AadiFit Performance Lab

Prevalence & Diagnosis

• PCOS affects an estimated 10–13% of women of reproductive age worldwide. (Source: World Health Organization, PCOS fact sheet)
• Up to 70% of women with PCOS remain undiagnosed globally. (Source: World Health Organization, PCOS fact sheet)
• Global PCOS prevalence was 12.1% using Rotterdam criteria, 7.9% using original NIH criteria, and 12.7% using Androgen Excess-PCOS Society criteria. (Source: Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis, Human Reproduction Update, Oxford Academic)
• By WHO region, prevalence using Rotterdam criteria is highest in the Eastern Mediterranean region (15.1%) and South-East Asia (14.3%). (Source: Global burden of polycystic ovary syndrome among women of childbearing age, 1990–2021, systematic analysis using GBD 2021 data)
• Diagnosed PCOS prevalence cases worldwide reached 65.77 million in 2021, an 89% increase from 1990. (Source: Global burden of polycystic ovary syndrome among women of childbearing age, 1990–2021, GBD 2021 study)

PCOS in India

• A meta-analysis of 11 Indian studies (2010–2021) found pooled PCOS prevalence of 11.33% using Rotterdam criteria. (Source: Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis, 2022, PMC)
• Using NIH criteria, the same review found a pooled prevalence of 5.8% among Indian women — roughly half the Rotterdam-criteria figure, reflecting how much diagnostic standard changes the count. (Source: Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis, 2022, PMC)
• Weighted national prevalence in India was 7.2% (NIH 1990 criteria) and 19.6% (Rotterdam 2003 criteria) in a separate large-scale analysis. (Source: Indian Journal of Medical Research, epidemiology review)
• PCOS prevalence is consistently higher in urban India than rural India across all diagnostic criteria, with the highest regional rates in Central and North India. (Source: Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis, 2022, PMC)

Which Exercise Type Works Best

From a 2025 Bayesian network meta-analysis of 19 randomized controlled trials (808 participants, 696 with usable HOMA-IR data) comparing six exercise interventions for insulin resistance in PCOS.

• Yoga ranked most effective for improving insulin resistance (HOMA-IR), with a SUCRA score of 90.73% and standardized mean difference of −0.73. (Source: The Effects of Different Exercises on Insulin Resistance and Testosterone Changes in Women with PCOS: A Network Meta-Analysis, 2025, PMC)
• High-intensity interval training (HIIT) ranked second for insulin resistance improvement, with a SUCRA score of 74.12% (SMD −0.47). (Source: Network Meta-Analysis Study, 2025, PMC)
• Moderate-intensity continuous training (MICT) scored 50.56% SUCRA — roughly a coin-flip's worth of relative effectiveness against the other five interventions tested. (Source: Network Meta-Analysis Study, 2025, PMC)
• Resistance training alone ranked least effective for insulin resistance specifically, with a SUCRA of 32.53% (SMD −0.13) — though it remains valuable for body composition and strength outcomes not measured by this analysis. (Source: Network Meta-Analysis Study, 2025, PMC)
• In a separate 8-week pilot RCT, unsupervised vigorous exercise (75 min/week) showed no significant metabolic advantage over moderate exercise (150 min/week) — fasting glucose actually moved less favorably in the vigorous arm (+8.06% vs. −0.32%). (Source: Vigorous vs. moderate exercise to improve glucose metabolism in inactive women with PCOS, 2023, F&S Reports / PMC)

Weight & Body Composition

• Lifestyle interventions (diet, exercise, behavioral coaching, or combined) produced mean weight change ranging from +0.5% to −10.6% of initial body weight across studies. (Source: Implementing the international evidence-based guideline: how to achieve weight loss in overweight and obese women with PCOS, ScienceDirect)
• In a 12-month North India pilot study (60 women with PCOS), 20 weeks of home-based aerobic exercise took body weight from 67.4kg to 62.7kg and BMI from 22.8 to 21.1 kg/m² — the control group showed no meaningful change over the same period. (Source: The Effect of Exercise Training on Body Composition, Insulin Resistance and Hs-CRP in Women With PCOS: A Pilot Study From North India, Cureus, 2022)
• In the same study, HOMA-IR (insulin resistance) fell from 3.2 to 1.9, and hs-CRP (an inflammation marker) dropped from 6.7 to 4.2 mg/L, both statistically significant. (Source: The Effect of Exercise Training on Body Composition, Insulin Resistance and Hs-CRP in Women With PCOS: A Pilot Study From North India, Cureus, 2022)

Mental Health

• Pooled prevalence of depressive symptoms among women with PCOS is 42.1%, versus 13.6% in controls without PCOS — from a meta-analysis of 32 studies (2,547 observations). (Source: Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis, MDPI, 2025)
• Pooled prevalence of anxiety symptoms among women with PCOS is 42.8% (95% CI: 32.8–53.4%), from 22 studies (2,786 observations). (Source: Depressive and Anxiety Symptoms in Women with Polycystic Ovary Syndrome: A Meta-Analysis, MDPI, 2025)
• In low- and middle-income countries specifically, pooled depression prevalence is 51% (95% CI: 43–59%) and anxiety 45% (95% CI: 36–54%). (Source: Depression and anxiety among women with PCOS in low- and middle-income countries: a systematic review and meta-analysis, Frontiers in Global Women's Health, 2025)
• Women aged 20–25 with PCOS in LMIC data show depression at 63% and anxiety at 56%, versus 49% for both in the 26–30 age band. (Source: Depression and anxiety among women with PCOS in low- and middle-income countries, Frontiers, 2025)
• Indian studies within the same LMIC review reported depression at 55% and anxiety at 51% — both above the overall LMIC average. (Source: Depression and anxiety among women with PCOS in low- and middle-income countries, Frontiers, 2025)

Barriers to Exercise

From a 2024/2025 qualitative study using semi-structured interviews with women with PCOS, analysed by reflexive thematic analysis.

• Competing life priorities — work, family, and household duties — consistently displaced exercise once initial motivation faded. (Source: A qualitative analysis of factors influencing physical activity behaviour in women with PCOS, Health Education Research / PMC)
• PCOS symptoms themselves formed a barrier: low mood and fatigue reduced activity, and reduced activity worsened mood, in a self-reinforcing cycle described by participants. (Source: A qualitative analysis of factors influencing physical activity behaviour in women with PCOS, Health Education Research / PMC)
• Slow visible progress on weight was a reported demotivator — participants described disengaging from exercise when they didn't see the benefit. (Source: A qualitative analysis of factors influencing physical activity behaviour in women with PCOS, Health Education Research / PMC)
• Fear of judgment in group exercise settings, and fitness professionals lacking PCOS-specific knowledge, were both cited as reasons participants avoided or abandoned structured programs. (Source: A qualitative analysis of factors influencing physical activity behaviour in women with PCOS, Health Education Research / PMC)

Official Guidelines

• The 2023 International Evidence-based Guideline recommends adults with PCOS get 150–300 minutes of moderate-intensity activity (or 75–150 minutes vigorous) per week for weight maintenance, plus resistance training on 2 non-consecutive days. (Source: Recommendations From the 2023 International Evidence-based Guideline for PCOS, Journal of Clinical Endocrinology & Metabolism, Oxford Academic)
• For greater health benefit beyond basic weight maintenance, the same guideline recommends 250 min/week moderate or 150 min/week vigorous activity. (Source: 2023 International Evidence-based Guideline, JCEM)
• Adolescents with PCOS are recommended at least 60 minutes of moderate-to-vigorous activity daily, including muscle- and bone-strengthening activity at least 3 times per week. (Source: 2023 International Evidence-based Guideline, JCEM)